Phenotype, Genotype & Biomarkers in ALS and Related Disorders

Enrolling by invitationOBSERVATIONAL
Enrollment

700

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

July 31, 2026

Study Completion Date

August 31, 2026

Conditions
Amyotrophic Lateral SclerosisFrontotemporal DementiaPrimary Lateral SclerosisHereditary Spastic ParaplegiaProgressive Muscular AtrophyMultisystem Proteinopathy
Trial Locations (15)

19104

University of Pennsylvania, Philadelphia

22908

University of Virginia (UVA), Charlottesville

27157

Wake Forest University, Winston-Salem

33136

University of Miami, Miami

44195

Cleveland Clinic, Cleveland

52242

University of Iowa, Iowa City

55415

Twin Cities ALS Research Consortium, Minneapolis

66160

Kansas University Medical Center (KUMC), Kansas City

75390

University of Texas Southwestern (UTSW), Dallas

78229

University of Texas Health Science Center San Antonio (UTHSCSA), San Antonio

92093

University of California San Diego (UCSD), San Diego

94115

California Pacific Medical Center (CPMC), San Francisco

94304

Stanford University, Palo Alto

Unknown

Eberhard Karls University of Tübingen, Tübingen

University of Cape Town, Cape Town

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

collaborator

St. Jude Children's Research Hospital

OTHER

collaborator

ALS Association

OTHER

lead

University of Miami

OTHER